ATHA - Athira Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Athira Pharma's activity chart (see below) currently has 23 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 12.32% of the time, taking 39.88 days on average.

Most recent stock forecast was given by from MIZUHO on 19-Sep-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jul-2022

$5

$500

2 years 2 months 2 days ago
(19-Sep-2024)

2/4 (50%)

$0.35 (7.53%)

251

Buy Since 24-Mar-2023

2 years 2 months 17 days ago
(04-Sep-2024)

0/2 (0%)

$161.9 (576.16%)

Buy Since 10-May-2022

$100

2 years 2 months 17 days ago
(04-Sep-2024)

0/2 (0%)

$75.4 (306.50%)

Hold Since 29-May-2023

$50

3 years 5 months 23 days ago
(29-May-2023)

0/3 (0%)

$21.5 (75.44%)

Buy Since 13-Oct-2020

$30

$320

4 years 4 months 29 days ago
(23-Jun-2022)

2/7 (28.57%)

$2.5 (9.09%)

35

Show more analysts

Please expand the browser size to see the chart

What is ATHA (Athira Pharma) average time for price targets to be met?

On average it took 40 days for the stock forecasts to be reached, with an average price target met ratio of 12.32%.

Which analyst most recently updated their price target on ATHA (Athira Pharma)?

Which analyst has the most public recommendations on ATHA (Athira Pharma)?

has 0 price targets and 0 ratings on ATHA

Which analyst is the currently most bullish on ATHA (Athira Pharma)?

Corinne Jenkins with the highest potential upside of $1592.34

Which analyst is the currently most reserved on ATHA (Athira Pharma)?

Graig Suvannavejh with the lowest potential downside of -$2.66
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?